Long-term Effects of Family WISH Program for Adolescents With Congenital Heart Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Family Walking Instruction with Support by Heart (Family WISH) program, Comparison group.
- Who it may be relevant to
- Registry conditions: Heart Defects, Congenital. Basic parameters: 12 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this clinical trial is to learn the long-term effects of "Family Walking Instruction with Support by Heart" (Family WISH) on frailty state, quality of life and family functioning among adolescents with congenital heart disease (CHD). Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program. Participants will: * Walk with family members for 20-30 minutes daily, at least 5 times per week, totaling 150 minutes per week. * Keep a diary to record the frequency of their walks and any symptoms experienced. * Complete questionnaires at baseline, and at 6, 12, and 24 weeks.
Interventions
- Behavioral Family Walking Instruction with Support by Heart (Family WISH) program
Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program. - Behavioral Comparison group
a family walking health education sheet received
Primary outcome measures
- frailty state [Time frame: at baseline, and at 6, 12, and 24 weeks]
Secondary outcome measures (1)
- quality of life and family functioning [Time frame: at baseline, and at 6, 12, and 24 weeks]
Eligibility criteria
Inclusion criteria
- being between 12 and 18 years old;
- having received a diagnosis of CHD by a physician before age 2;
- having received a diagnosis of CHD with New York Heart Association (NYHA) functional class I, II, or III;
- having parents or guardians who were able to communicate in Mandarin, and being able to communicate in Mandarin themselves;
- not having cognitive impairments, and;
- voluntarily signing informed consent forms.
Exclusion criteria
- undergoing heart transplant surgery within the past year;
- receiving cardiac catheterization intervention or open-heart surgery within the past 6 months;
- having CHD with NYHA functional class IV; and
- having other congenital diseases
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
Taiwan · 1 center
- College of Nursing, National Yang Ming Chiao Tung University — Taipei
Identifiers
NCT: NCT06719323 · 202401204RINC